Botryococcus braunii as a bioreactor for the production of nanoparticles with antimicrobial potentialities
Received 15 May 2018
Accepted for publication 3 July 2018
Published 20 September 2018 Volume 2018:13 Pages 5591—5604
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Alexander Kharlamov
Peer reviewer comments 2
Editor who approved publication: Dr Thomas Webster
Alejandra Arévalo-Gallegos,1 J Saul Garcia-Perez,1 Danay Carrillo-Nieves,1 RA Ramirez-Mendoza,1 Hafiz MN Iqbal,1 Roberto Parra-Saldívar1–4
1Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Campus Monterrey, Monterrey, Nuevo León, Mexico; 2Microsystems Technologies Laboratories, Massachusetts Institute of Technology, Cambridge, MA, USA; 3Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA; 4Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
Background: Microalgae produce metabolites with notable potentialities to act as reducing and capping agents for the synthesis of silver nanoparticles (AgNPs) in a process widely recognized as an eco-friendly and cheaper alternative for the generation of nanoparticles (NPs).
Methods: In the present work, AgNPs were synthesized using live Botryococcus braunii cultures. Two biosynthesis routes were explored: (1) intracellular and (2) extracellular at pH levels of 6–9 using 1–5 mM silver nitrate concentrations.
Results: The generation of NPs was confirmed via ultraviolet–visible spectroscopy. The morphological characteristics were observed using scanning electron microscopy which revealed that the newly developed AgNPs were mostly spherical in sizes starting from 168 nm. The characteristic peaks in a typical Fourier transform infrared spectroscopy suggested that the exopolysaccharides were the possible reducing and capping agents. The antimicrobial spectrum of the newly developed AgNPs was tested against bacterial strains, both Gram-negative, Gram-positive, and yeast, ie, Escherichia coli (American Type Culture Collection [ATCC] 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), and the yeast Candida albicans (ATCC 10231), respectively. The antimicrobial activity tests showed a stronger inhibition against Gram-negative bacteria. Statistically, the NPs biosynthesized at pH values of 6 and 8 displayed a higher antimicrobial activity.
Conclusion: Our findings showed that B. braunii is capable of generating AgNPs with antimicrobial potential.
Keywords: biosynthesis, microalgae, silver nanoparticles, antimicrobial activity
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]